Breaking News

PharmaLogic to Acquire Majority Stake in Agilera

Will complement PharmaLogic's existing manufacturing platform for therapeutics, enhancing the company's ability to deliver radiopharmaceutical solutions.

Author Image

By: Charlie Sternberg

Associate Editor

PharmaLogic Holdings Corp., a contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, has agreed to acquire a majority stake in Agilera Pharma AS from the Institute for Energy Technology (IFE) in Norway, marking a significant step forward in the company’s strategy to create the first fully-integrated, global CDMO specializing in radiopharmaceutical therapies. Agilera has been a partner for major pharmaceutical companies for more than a decade, ma...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters